title: Haemolytic uraemic syndrome, cardiomyopathy, cutaneous vasculopathy and anti-phospholipid activity.
authors.forename: M
authors.initials: M
authors.lastname: do Sameiro Faria
authors.forename: C
authors.initials: C
authors.lastname: Mota
authors.forename: J
authors.initials: J
authors.lastname: Barbot
authors.forename: S
authors.initials: S
authors.lastname: Alvares
authors.forename: H
authors.initials: H
authors.lastname: Jardim
authors.forename: A
authors.initials: A
authors.lastname: Vilarinho
authors.forename: E
authors.initials: E
authors.lastname: Pereira
mesh_terms: D058186:Acute Kidney Injury / Q000209:etiology* / Q000628:therapy; D016736:Antiphospholipid Syndrome / Q000150:complications* / Q000628:therapy; D009202:Cardiomyopathies / Q000150:complications* / Q000628:therapy; D002648:Child; D006463:Hemolytic-Uremic Syndrome / Q000150:complications* / Q000628:therapy; D006801:Humans; D016285:Iloprost / Q000627:therapeutic use; D008297:Male; D016491:Peripheral Vascular Diseases / Q000150:complications*; D010531:Peritoneal Dialysis, Continuous Ambulatory; D010956:Plasmapheresis; D012867:Skin / Q000098:blood supply
chemical_list: D016285:Iloprost